INFIMAB (Infliximab Powder (r DNA origin)-100mg

INFIMAB (Infliximab) is a recombinant chimeric human-murine IgG1, monoclonal antibody, which binds to both soluble and trans membrane forms of the human tumor necrosis factor (TNF)a and inhibits the functional activity of TNFa. It works by blocking the actions of a certain natural substance (tumor necrosis factor alpha) in the body. This helps to decrease swelling (inflammation) and weaken your immune system, which slows or stops the damage from the disease. 

An immunosuppressant drug, it is commonly used to treat autoimmune & various inflammatory conditions of

  • the joints (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis),
  • skin (psoriasis), and
  • bowel (ulcerative colitis, Crohn’s disease).
Enquiry Now
Category:

Additional information

Trade Name

INFIMAB

Generic Name

Infliximab Powder (r DNA origin)

Manufacturer

Sun Pharmaceutical Industries Ltd

Drug Type

Miscellaneous

Indication

Antiinflammatory

Doasage Form

Injectible

Packaging

1 x 100mg